Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis.

about

Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects

P2860

Q59125679-8670B44C-51C0-4248-961C-2686855162E2

P2860

Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis.

Item

http://www.wikidata.org/entity/Q47325125

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Usability and Patient Preferen ...... o-Severe Rheumatoid Arthritis.

@en

Usability and Patient Preferen ...... o-Severe Rheumatoid Arthritis.

@nl

type

Item

label

Usability and Patient Preferen ...... o-Severe Rheumatoid Arthritis.

@en

Usability and Patient Preferen ...... o-Severe Rheumatoid Arthritis.

@nl

prefLabel

Usability and Patient Preferen ...... o-Severe Rheumatoid Arthritis.

@en

Usability and Patient Preferen ...... o-Severe Rheumatoid Arthritis.

@nl

P1476

Usability and Patient Preferen ...... o-Severe Rheumatoid Arthritis.

@en

P2093

Alan Kivitz

http://www.w3.org/2001/XMLSchema#string

Christine Xu

http://www.w3.org/2001/XMLSchema#string

Hubert van Hoogstraten

http://www.w3.org/2001/XMLSchema#string

Janie Parrino

http://www.w3.org/2001/XMLSchema#string

Lydie Baret-Cormel

http://www.w3.org/2001/XMLSchema#string

Marina Stanislav

http://www.w3.org/2001/XMLSchema#string

Sheldon Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Immunogenicity of biologic agents in rheumatoid arthritis patients: lessons for clinical practice

Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury

Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.

Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study.

Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis.

Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis.

Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe.

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor.

Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors.

P2888

s40744-017-0090-2

P304

231-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40744-017-0090-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29209946

http://www.w3.org/2001/XMLSchema#string

P932

5935610

http://www.w3.org/2001/XMLSchema#string

Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis.

about

P2860

P2860

Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932